Development of a Bioavailable μ Opioid Receptor (MOPr) Agonist, δ Opioid Receptor (DOPr) Antagonist Peptide That Evokes Antinociception without Development of Acute Tolerance

Development of a Bioavailable μ Opioid Receptor (MOPr) Agonist, δ Opioid Receptor (DOPr) Antagonist Peptide That Evokes Antinociception without Development of Acute Tolerance

Bibliographic Details
Main Authors: Mosberg, Henry I., Yeomans, Larisa, Anand, Jessica P., Porter, Vanessa, Sobczyk-Kojiro, Katarzyna, Traynor, John R., Jutkiewicz, Emily M.
Format: Online
Language:English
Published: American Chemical Society 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993928/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993928/

Similar Items